InspireMD (NSPR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.46, -5.17% vs the prior close of $0.48.
- Volume 94.63K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NSPR slides 5.2% to $0.46, a 52-week low. Closed at $0.46, -5.17% vs the prior close of $0.48. Day range $0.45β$0.48, opened at $0.48.
NSPR daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β NSPR slides 5.2% to $0.46, a 52-week low
- Closed at $0.46, -5.17% vs the prior close of $0.48. Day range $0.45β$0.48, opened at $0.48.
- Volume was 94.63K shares, 1.0x its 50-day average of 98.02K.
- Price is -39.0% vs its 50-day average ($0.75) and -59.9% vs its 200-day average ($1.14).
- 52-week range $0.45β$2.42; today's close sits at 0% of that range, 81.2% below the 52-week high.
Oct 15, 2026 β NSPR rises 2.1% to $0.48
- Closed at $0.48, +2.13% vs the prior close of $0.47. Day range $0.48β$0.51, opened at $0.49.
- Volume was 60.00K shares, 0.6x its 50-day average of 97.61K.
- Price is -36.2% vs its 50-day average ($0.75) and -58.0% vs its 200-day average ($1.14).
- 52-week range $0.46β$2.54; today's close sits at 1% of that range, 81.1% below the 52-week high.
Oct 14, 2026 β NSPR slides 6.0% to $0.47, a 52-week low on 2.1x normal volume
- Closed at $0.47, -6.00% vs the prior close of $0.50. Day range $0.46β$0.50, opened at $0.48.
- Volume was 198.70K shares, 2.1x its 50-day average of 96.41K β unusually heavy trading.
- Price is -37.9% vs its 50-day average ($0.76) and -59.1% vs its 200-day average ($1.15).
- 52-week range $0.46β$2.54; today's close sits at 0% of that range, 81.5% below the 52-week high.
Oct 13, 2026 β NSPR rises 2.0% to $0.50
- Closed at $0.50, +2.04% vs the prior close of $0.49. Day range $0.48β$0.57, opened at $0.54.
- Volume was 96.60K shares, 1.0x its 50-day average of 95.26K.
- Price is -34.3% vs its 50-day average ($0.76) and -56.8% vs its 200-day average ($1.16).
- 52-week range $0.46β$2.54; today's close sits at 2% of that range, 80.3% below the 52-week high.
Oct 12, 2026 β NSPR slides 5.8% to $0.49
- Closed at $0.49, -5.77% vs the prior close of $0.52. Day range $0.49β$0.54, opened at $0.52.
- Volume was 90.60K shares, 1.0x its 50-day average of 94.90K.
- Price is -36.0% vs its 50-day average ($0.77) and -57.9% vs its 200-day average ($1.16).
- 52-week range $0.46β$2.54; today's close sits at 1% of that range, 80.7% below the 52-week high.
Oct 9, 2026 β NSPR jumps 8.3% to $0.52 on 3.6x normal volume
- Closed at $0.52, +8.33% vs the prior close of $0.48. Day range $0.49β$0.59, opened at $0.51.
- Volume was 327.10K shares, 3.6x its 50-day average of 89.85K β unusually heavy trading.
- Price is -32.3% vs its 50-day average ($0.77) and -55.7% vs its 200-day average ($1.17).
- 52-week range $0.46β$2.54; today's close sits at 3% of that range, 79.5% below the 52-week high.
Oct 8, 2026 β NSPR slides 5.9% to $0.48, a 52-week low on 2.6x normal volume
- Closed at $0.48, -5.88% vs the prior close of $0.51. Day range $0.46β$0.53, opened at $0.50.
- Volume was 225.40K shares, 2.6x its 50-day average of 86.09K β unusually heavy trading.
- Price is -37.8% vs its 50-day average ($0.77) and -59.4% vs its 200-day average ($1.18).
- 52-week range $0.46β$2.54; today's close sits at 1% of that range, 81.1% below the 52-week high.
- That makes 12 straight losses.
Oct 7, 2026 β NSPR slides 3.8% to $0.51, a 52-week low, 11 down days in a row
- Closed at $0.51, -3.77% vs the prior close of $0.53. Day range $0.50β$0.59, opened at $0.54.
- Volume was 145.20K shares, 1.7x its 50-day average of 84.12K.
- Price is -34.2% vs its 50-day average ($0.78) and -57.1% vs its 200-day average ($1.19).
- 52-week range $0.50β$2.54; today's close sits at 0% of that range, 79.9% below the 52-week high.
- That makes 11 straight losses.
Oct 6, 2026 β NSPR slides 8.6% to $0.53, a 52-week low on 2.9x normal volume
- Closed at $0.53, -8.62% vs the prior close of $0.58. Day range $0.50β$0.65, opened at $0.60.
- Volume was 230.30K shares, 2.9x its 50-day average of 80.07K β unusually heavy trading.
- Price is -31.9% vs its 50-day average ($0.78) and -55.7% vs its 200-day average ($1.20).
- 52-week range $0.50β$2.57; today's close sits at 1% of that range, 79.4% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 β NSPR slides 6.5% to $0.58, a 52-week low, 9 down days in a row
- Closed at $0.58, -6.45% vs the prior close of $0.62. Day range $0.58β$0.65, opened at $0.63.
- Volume was 136.20K shares, 1.8x its 50-day average of 77.65K.
- Price is -25.8% vs its 50-day average ($0.78) and -51.8% vs its 200-day average ($1.20).
- 52-week range $0.58β$2.57; today's close sits at 0% of that range, 77.4% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 β NSPR ends flat (+0.0%) to $0.62, 8 down days in a row
- Closed at $0.62, +0.00% vs the prior close of $0.62. Day range $0.61β$0.63, opened at $0.62.
- Volume was 65.70K shares, 0.9x its 50-day average of 76.57K.
- Price is -20.9% vs its 50-day average ($0.78) and -48.8% vs its 200-day average ($1.21).
- 52-week range $0.60β$2.57; today's close sits at 1% of that range, 75.9% below the 52-week high.
- That makes 8 straight losses.
NSPR latest news & SEC filings
Every SEC filing by or about NSPR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 23, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 23, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 21, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.77M (prior year $1.78M) (-0.4% vs Jun 30, 2025)
- Net income: -$14.32M (prior year -$13.15M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.17 (prior year -$0.26) (loss narrowed vs Jun 30, 2025)
Jul 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Jul 23, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Jul 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Things to know before you trade NSPR
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Mar 18, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.89% (largest 8.6%). That is a volatile stock.
- Liquidity: about 123.27K shares (β$56.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.46 vs a range of $0.45β$2.42 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 21 open-market buys, 4 sales; latest: Paul Stuka bought 20,000 shares on May 27, 2026.
- Latest filings: 8-K Sep 21, 2026; 8-K Aug 17, 2026; 10-Q Aug 14, 2026.
- Share count: 46.49M shares outstanding (Aug 14, 2026), +11.4% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
NSPR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.48 | 0.48 | 0.45 | 0.46 | 94.63K |
| Oct 15, 2026 | 0.49 | 0.51 | 0.48 | 0.48 | 60.00K |
| Oct 14, 2026 | 0.48 | 0.50 | 0.46 | 0.47 | 198.70K |
| Oct 13, 2026 | 0.54 | 0.57 | 0.48 | 0.50 | 96.60K |
| Oct 12, 2026 | 0.52 | 0.54 | 0.49 | 0.49 | 90.60K |
| Oct 9, 2026 | 0.51 | 0.59 | 0.49 | 0.52 | 327.10K |
| Oct 8, 2026 | 0.50 | 0.53 | 0.46 | 0.48 | 225.40K |
| Oct 7, 2026 | 0.54 | 0.59 | 0.50 | 0.51 | 145.20K |
| Oct 6, 2026 | 0.60 | 0.65 | 0.50 | 0.53 | 230.30K |
| Oct 5, 2026 | 0.63 | 0.65 | 0.58 | 0.58 | 136.20K |
| Oct 2, 2026 | 0.62 | 0.63 | 0.61 | 0.62 | 65.70K |
| Oct 1, 2026 | 0.71 | 0.71 | 0.61 | 0.62 | 86.90K |
| Sep 30, 2026 | 0.70 | 0.71 | 0.61 | 0.67 | 178.00K |
| Sep 29, 2026 | 0.70 | 0.70 | 0.60 | 0.69 | 149.30K |
| Sep 28, 2026 | 0.70 | 0.71 | 0.67 | 0.69 | 23.50K |
| Sep 25, 2026 | 0.71 | 0.71 | 0.69 | 0.70 | 52.70K |
| Sep 24, 2026 | 0.73 | 0.74 | 0.70 | 0.70 | 67.70K |
| Sep 23, 2026 | 0.75 | 0.77 | 0.73 | 0.75 | 29.60K |
| Sep 22, 2026 | 0.75 | 0.81 | 0.75 | 0.76 | 138.10K |
| Sep 21, 2026 | 0.77 | 0.82 | 0.75 | 0.75 | 69.20K |
About InspireMD
InspireMD (NSPR) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in MIAMI, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1433607.
NSPR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kathryn Arnold | Director | Dec 31, 2025 |
| Michael Berman | Director | Sep 23, 2026 |
| Raymond W Cohen | Director | Jan 16, 2026 |
| Danny L. Dearen | Director | Jan 16, 2026 |
| Gary S Roubin | Director | Sep 23, 2026 |
| Marvin Slosman | CEO and President | May 13, 2026 |
| Paul Stuka | Director | Sep 23, 2026 |
| Scott R. Ward | Director | May 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Shane Thomas Gleason | Chief Commercial Officer | May 21, 2026 |
| Michael A Lawless | Chief Financial Officer | Jan 16, 2026 |
| Marvin Slosman | CEO and President | May 13, 2026 |
| Andrea Tommasoli | Chief Operating Officer | Jan 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 27, 2026 | Paul Stuka | Buy | 20,000 | $0.88 |
| May 27, 2026 | Paul Stuka | Buy | 20,000 | $0.88 |
| May 27, 2026 | Paul Stuka | Buy | 20,000 | $0.88 |
| May 27, 2026 | Paul Stuka | Buy | 20,000 | $0.88 |
| May 19, 2026 | Shane Thomas Gleason | Sale | 22,778 | $1.01 |
| May 19, 2026 | Shane Thomas Gleason | Sale | 22,778 | $1.01 |
| May 19, 2026 | Shane Thomas Gleason | Sale | 22,778 | $1.01 |
| May 19, 2026 | Shane Thomas Gleason | Sale | 22,778 | $1.01 |
| May 14, 2026 | Paul Stuka | Buy | 5,000 | $1.15 |
| May 14, 2026 | Paul Stuka | Buy | 5,000 | $1.15 |
| May 14, 2026 | Paul Stuka | Buy | 5,000 | $1.15 |
| May 14, 2026 | Paul Stuka | Buy | 5,000 | $1.15 |
| May 13, 2026 | Paul Stuka | Buy | 10,000 | $1.16 |
| May 13, 2026 | Paul Stuka | Buy | 10,000 | $1.16 |
| May 13, 2026 | Paul Stuka | Buy | 10,000 | $1.16 |
NSPR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $8.98M | $-48.79M | -0.76 | $-35.10M |
| Dec 31, 2024 | $7.01M | $-32.01M | -0.76 | $-21.87M |
| Dec 31, 2023 | $6.21M | $-19.92M | -0.82 | $-16.38M |
| Dec 31, 2022 | $5.17M | $-18.49M | -2.35 | $-15.54M |
| Dec 31, 2021 | $4.50M | $-14.92M | β | $-13.21M |
Latest balance sheet: total assets $44.64M, total liabilities $13.13M, cash $15.15M (as of Jun 30, 2026).
NSPR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $0.88 |
| May 4, 2026 | 8-K Item 2.02 (results) | $1.17 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $1.79 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $2.13 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $2.45 |
| May 9, 2025 | 8-K Item 2.02 (results) | $2.60 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $2.81 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | β |
| May 14, 2024 | 8-K Item 2.02 (results) | β |
| Mar 6, 2024 | 8-K Item 2.02 (results) | β |
| Nov 6, 2023 | 8-K Item 2.02 (results) | β |
| Aug 8, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NSPR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.